32 Countries with the Highest Rates of Diabetes

Published on March 26, 2024 at 5:10 am by Laiba Immad in Lists, News

In this article, we will be taking a look at the 32 countries with the highest rates of diabetes. If you do not want to learn about the global diabetes market, head straight to the 5 Countries with the Highest Rates of Diabetes.

The Global Diabetes Market and Its Implications

The global diabetes market is experiencing significant growth and poses a substantial challenge to public health worldwide. According to the IDF Diabetes Atlas, in 2021, approximately 537 million people were suffering from diabetes globally, a number expected to rise to 643 million by 2030 and 783 million by 2045. This increase in prevalence underscores the urgent need for effective measures to address this chronic disease.

In the United States, the diabetes market is substantial, with around 136 million adults diagnosed with diabetes or in a prediabetic condition as reported by the Centers for Disease Control and Prevention. The U.S. market is dominated by key players such as Abbott, Medtronic, Dexcom, and Insulet Corporation. North America held a significant share of the global diabetes devices market at 38.66% in 2022, driven by a large patient population and favorable reimbursement conditions.

Financially, the global diabetes devices market was estimated at USD 30.31 billion in 2023 and is projected to grow at a compound annual growth rate of 7.45% from 2024 to 2030, reaching USD 32.70 billion. North America led this market in 2022, reflecting the region’s high patient numbers and supportive reimbursement environment. Key factors propelling market growth include increasing diabetes incidence, technological advancements in preventive care, and rising demand for blood glucose monitoring devices.

The Diabetic Dilemma: A Global Economic Crisis

The global diabetes epidemic looms large, claiming over 280,000 lives annually. Government initiatives and the development of affordable drugs like oral hypoglycemics are driving market expansion. The toll of diabetes contributes significantly to the global disease burden, estimated at a staggering $16.3 trillion over two decades. Insulin, a lifeline for millions worldwide, experiences soaring demand, particularly in emerging economies. Notably, 94% of insulin pump users reported enhanced quality of life in 2023, fostering robust growth in the insulin pump market, projected to reach $11.4 billion by 2032, growing at an 8.5% CAGR.

In the United States, insulin costs have surged by over 600% in the last two decades, leading one in four diabetics to ration their supply due to financial constraints. However, investing in affordable options such as biosimilars and generics can alleviate this burden. Major pharmaceutical giants like Sanofi, Eli Lilly and Company, and Novo Nordisk have the potential to mitigate the financial strain on patients and healthcare systems alike. In 2017 alone, diabetes inflicted a staggering 327 billion blow to the US economy, with direct medical expenses totaling $237 billion. Laboratory costs for diabetes management vary widely, ranging from under $5 to over $100 per patient annually.

Sanofi (NASDAQ:SNY), a leading global healthcare company with a century-long legacy, has been instrumental in advancing diabetes treatment and management. Their commitment to developing cutting-edge treatments like TZIELD for Stage 3 type 1 diabetes demonstrates their dedication to enhancing health outcomes. Additionally, their exploration of AI-driven systems for blood glucose analysis reflects a commitment to individualized diabetes support. In Q4 2023, despite a 5% decrease in operating income attributed to various factors, Sanofi (NASDAQ:SNY) experienced significant sales growth, particularly with the anti-inflammatory drug Dupixent. Sanofi (NASDAQ:SNY) anticipates a rebound in adjusted earnings per share in 2025 following a slight decline in 2024. Additionally, Sanofi announced a new chief financial officer, Francois-Xavier Roger, from Nestle, effective April 1, succeeding Jean-Baptiste de Chatillon.

Novo Nordisk A/S (NYSE:NVO), a leading player in the diabetes market, has strengthened its position with a market share increase to 54.9% in 2022. The company dominates the global insulin market with nearly 50% share by volume. Novo Nordisk A/S (NYSE:NVO)’s success lies in innovative products like Ozempic and Wegovy, driving impressive sales growth and enabling it to address unmet needs in type 2 diabetes and obesity.

Anticipating continued growth, Novo Nordisk A/S (NYSE:NVO) expects sales to increase by 18% to 26% this year, fueled by demand for key products. Despite competition, especially in the weight loss segment, the company is confident in meeting market demands through strategic investments.

Our Methodology

For our methodology, we have ranked the countries with the highest rates of diabetes based on age-standardized diabetes rates in these countries in 2021. For the accuracy of data, we relied on IDF Diabetes Atlas.

Here is our list of the 32 countries with the highest rates of diabetes.

32. Bangladesh

Diabetes Rate: 14.2%

In Bangladesh, diabetes prevalence has surged from 4.5% to 35% between 1994 and 2013. In 2019, 8.4 million adults had diabetes, projected to double by 2045. Prevalence among adults aged 35+ rose from 10.95% in 2011 to 13.75% in 2018, notably among obese individuals. Both genders are affected equally, with prevalence increasing with age.

31. Belize

Diabetes Rate: 14.5%

Belize faces a severe health challenge with a high prevalence of type 2 diabetes (T2D), reaching over 17% in adults, making it the highest in Central and South America and the fifth globally. T2D is now the leading cause of death in Belize, with 33% of the population in the prediabetes range. Diabetes affects both genders, primarily adults aged 20 to 79.

30. Turkey

Diabetes Rate: 14.5%

Turkey has diabetes prevalence of around 14.5% among adults aged 20 to 79, showing an increasing trend from 12.2% in 2014 to 13.2% in 2016. Women represent about three in five cases, with a prevalence of 13.10% compared to 9.12% in men. The diabetes therapeutics market is expected to grow to $2.5 billion by 2030, with Nobel İlaç, Koçak Farma, and GlaxoSmithKline as key players.

29. Syria

Diabetes Rate: 14.9%

Syria stands among the countries with the highest rates of diabetes, totaling 2,918,314 individuals affected. In 2017, adult diabetes cases numbered 705,700, with 12.6% prevalence in females and 11.2% in males. Approximately 400,000 Syrians rely on insulin for survival due to diabetes. Prevalence in Aleppo before 2011 was 14.8% among adults over 25. A cross-sectional survey of Syrian refugees in Jordan found a 5.3% prevalence, with higher rates among those over 60.

28. Tonga

Diabetes Rate: 15%

In Tonga, 15% of the population faces diabetes, making Tonga stand among the countries with the highest diabetes rates globally. Diabetes predominantly affects adults, especially those aged 41-60. Nearly all Tongans aged 18–69 are at risk for non-communicable diseases, including diabetes.

27. Jordan

Diabetes Rate: 15.4%

Jordan grapples with a diabetes challenge, with an estimated 866,500 cases in 2021 projected to rise to 1,629,100 by 2045. Diabetes-related health expenditure was USD 849.8 million in 2021, rising to USD 1,234.2 million by 2045, with per capita spending increasing significantly. The most affected age group is 20-79.

26. Micronesia

Diabetes Rate: 15.6%

The Federated States of Micronesia (FSM) stands among the top countries with high rates of diabetes, with a staggering 15.6% prevalence rate as of 2021, attributed to lifestyle changes and a shift to processed foods. Both genders and various age groups are affected. Access to insulin and diabetes treatment is hindered by remoteness, limited healthcare infrastructure, and financial constraints.

25. Vanuatu

Diabetes Rate: 15.6%

In Vanuatu, diabetes affects 1 in 11 people. Both men and women are impacted. Children are also affected by type 1 diabetes, with 10.9% going undiagnosed, emphasizing the need for early detection and improved healthcare services.

24. Saint Kitts and Nevis

Diabetes Rate: 16.1%

Saint Kitts and Nevis stand among the countries with the highest rates of diabetes, with a prevalence rate of 16.9%, concentrated in the 45-64 age group, affecting both genders similarly. Comorbidities are prevalent among diabetics, with 76% experiencing additional health issues. By 2045, the North American and Caribbean region, including St. Kitts and Nevis, is projected to have 63 million diabetes cases.

23. United Arab Emirates

Diabetes Rate: 16.4%

The United Arab Emirates (UAE) has a diabetes prevalence rate of 12.3% among adults, totaling around 990,900 cases. In the Northern Emirates, UAE citizens exhibit a 25.1% prevalence. Diabetes prevalence is highest among UAE nationals and Asian non-Arabs, with males at 21% and females at 23%. Healthcare expenditure on diabetes was USD 2,090.4 million in 2021, projected to rise to USD 2,329.3 million by 2030, equating to USD 2,109.5 per person in 2021, and expected to reach USD 2,350.6 per person by 2030.

22. Papua New Guinea

Diabetes Rate: 16.7%

Papua New Guinea faces significant diabetes prevalence, with 14.6% of adults affected, totaling approximately 724,000 cases. Even rural areas report high rates, with a village study showing 8.9% diabetes and 5.7% impaired glucose tolerance. Both genders are impacted, with middle-aged individuals, aged 30 to 69, bearing the highest burden of diabetes-related mortality and cases.

21. Mexico

Diabetes Rate: 16.9%

Mexico had a diabetes prevalence rate of 16.9% in 2021, impacting around 14 million adults, making Mexico stand among the countries with the highest rates of diabetes. Additionally, 11 million adults have impaired glucose tolerance. Females have a higher risk of diabetes. Diabetes care clinics like Clinicas del Azucar provide affordable care, supported by investments aiming to establish 100 new clinics by 2024.

20. Palau

Diabetes Rate: 17%

Palau faces significant diabetes challenges, with 22% of adults diagnosed, totaling 3,015 individuals, and 66% undiagnosed. Financially, insurance contributions and investments totaled $10.5 million in 2023, but medical care payouts were $7.3 million, indicating strain on the system.

19. Fiji

Diabetes Rate: 17.7%

Fiji stands among the top countries with high rates of diabetes, with prevalence steadily increasing from 16% in 2011 to 17.7% in 2021, projected to reach 20.7% by 2045. The number of diabetes cases is rising, estimated at 99.2 thousand in 2021, and projected to reach 139.7 thousand by 2045. Diabetes affects both genders and various age groups, with a rapid rise attributed to factors like childhood obesity, gestational diabetes, and social transitions, particularly affecting individuals under 60.

18. Saudi Arabia

Diabetes Rate: 18.7%

Saudi Arabia grapples with high diabetes rates, with a prevalence of 17.7% in adults, totaling 4,274,100 cases. Males have a slightly higher prevalence than females, and the highest prevalence is among individuals aged 60 and above. The country faces a significant economic burden due to diabetes, with healthcare expenditure reaching $7,459.5 million in 2021, and a projected national burden exceeding $0.87 billion, excluding indirect costs.

17. Sudan

Diabetes Rate: 18.9%

Sudan faces with a national diabetes prevalence of 7.7% in adults projected to increase to 10.8% by 2035. Type 2 diabetes mellitus (T2DM) is particularly concerning, with a prevalence of 20.8% in eastern Sudan. Insulin plays a crucial role in treatment, especially for youth with T2DM, alongside medications like metformin, glibenclamide, glimepiride, and glipizide.

16. Malaysia

Diabetes Rate: 19%

In Malaysia, approximately 18.3% of adults were affected by diabetes, according to the National Diabetes Registry Report. The prevalence has steadily increased from 13.4% in 2015 to 18.3% in 2019. Elderly individuals, especially those aged 60 and above, bear the highest burden, with rates reaching 33.46%. Ethnic disparities exist, with Indians having the highest prevalence at 25.10%. Despite a high treatment rate of 87.5%, only 21.8% of treated individuals have their diabetes under control, indicating a need for improved management strategies.

15. Guam

Diabetes Rate: 19.1%

Guam had a diabetes prevalence rate of 19.1% in 2021, up from 13.7% in 2018. Approximately one in six residents is affected, with the indigenous Chamorro population experiencing higher rates. Individuals aged 45 and older are at higher risk, raising concerns due to Guam’s relatively young population.

14. Qatar

Diabetes Rate: 19.5%

Qatar faces a significant challenge with diabetes, with a prevalence of around 19.5%, expected to rise to 24% by 2050, making Qatar stand among the top countries with high rates of diabetes. The SMART clinic provides tailored care plans, emphasizing blood glucose, pressure, and lipid levels.

13. Solomon Islands

Diabetes Rate: 19.8%

The Solomon Islands had a diabetes prevalence rate of 19.8% in 2021. Both genders and various age groups are affected, with adults aged 30 to 69 being the most impacted. Despite the high prevalence, insulin usage remains low at approximately 6%, indicating a need for improved management strategies.

12. Tuvalu

Diabetes Rate: 20.3%

Tuvalu, a Pacific island nation, had a diabetes prevalence rate of 20.3%. Females have a slightly higher prevalence at 23.8% compared to males at 22.4%. The remote location and scarce healthcare facilities hinder access to essential treatments, including insulin, exacerbating the challenge of controlling the disease.

11. American Samoa

Diabetes Rate: 20.3%

American Samoa faces one of the world’s highest rates of diabetes, particularly among adults aged 20 to 79. The prevalence of Type 2 diabetes mellitus has been steadily increasing over the years, with projections indicating further escalation. Adults aged 25 to 64 have witnessed a significant rise in Type 2 diabetes prevalence, highlighting a growing health challenge in this age group.

10. Egypt

Diabetes Rate: 20.9%

Egypt faces a significant challenge with diabetes, with a prevalence rate of approximately 15.2% among adults. The number of adult diabetic patients was around 8,850,400 in early 2020 and is expected to rise significantly by 2035. Type 2 diabetes prevalence is approximately 15.6% among adults aged 20 to 79.

9. Kiribati

Diabetes Rate: 22.1%

Kiribati stands ninth among the countries with the highest rates of diabetes, with over 20% of adults affected by type 2 diabetes. Both genders and various age groups are impacted, including children with type 1 diabetes, highlighting gaps in healthcare awareness. Access to insulin is crucial for type 1 diabetes management, with early diagnosis being essential to prevent fatal consequences.

8. Mauritius

Diabetes Rate: 22.6%

Mauritius had a a diabetes prevalence rate of 26.5% among adults, totaling 250,400 cases. Both men and women have seen a substantial increase in diabetes prevalence over the years, with a 64% rise since 1987. The most affected age group is adults aged 20 to 79 years.

7. Marshall Islands

Diabetes Rate: 23%

The Republic of the Marshall Islands (RMI) is one of the countries with the highest global prevalence of diabetes. By 2045, the estimated number of diabetes cases is expected to rise from 9.1 thousand to 13.1 thousand, with an increase in prevalence from 23.0% to 26.0%. Diabetes-related health expenditure was USD 13.6 million in 2021, projected to reach USD 18.1 million by 2045, emphasizing its economic impact on healthcare spending.

6. Nauru

Diabetes Rate: 23.4%

Nauru stands sixth among the countries with the highest rates of diabetes, affecting both men and women. The prevalence of diabetes was reported at 23.4% in 2021, with risk factors including age, high cholesterol levels, and waist circumference. Older adults, especially those aged 55-64 years, are most vulnerable. The financial burden on the Nauru government due to diabetes was estimated at AUD12.8 million in 2017, emphasizing the need for effective management strategies.

Click to see and continue reading the 5 Countries with the Highest Rates of Diabetes.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

Published on September 27, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up